Suppr超能文献

采用直接进样 LC-MS-MS 技术对医院污水进出口废水中的药品和个人护理产品进行表征。

Characterization of Pharmaceuticals and Personal Care products in hospital effluent and waste water influent/effluent by direct-injection LC-MS-MS.

机构信息

United States Environmental Protection Agency, Region 2, Division of Environmental Science and Assessment Laboratory, 2890 Woodbridge Avenue, Edison, NJ 08837, USA.

United States Environmental Protection Agency, Region 8 Laboratory, 16194 W 45th Drive, Golden, CO 80403, USA.

出版信息

Sci Total Environ. 2015 Jun 15;518-519:459-78. doi: 10.1016/j.scitotenv.2015.02.104. Epub 2015 Mar 13.

Abstract

Two USEPA Regional Laboratories developed direct-injection LC/MS/MS methods to measure Pharmaceuticals and Personal Care Products (PPCPs) in water matrices. Combined, the laboratories were prepared to analyze 185 PPCPs (with 74 overlapping) belonging to more than 20 therapeutical categories with reporting limits at low part-per-trillion. In partnership with Suffolk County in NY, the laboratories conducted PPCP analysis on 72 samples belonging to 4 Water Systems (WS). Samples were collected at different stages of the WS (hospital effluents, WWTP influents/effluents) to assess PPCP relevance in hospital discharges, impact on WWTP performance and potential ecological risk posed by analytes not eliminated during treatment. Major findings include: a) acceptable accuracy between the two laboratories for most overlapping PPCPs with better agreement for higher concentrations; b) the measurement of PPCPs throughout all investigated WS with total PPCP concentrations ranging between 324 and 965 μg L(-1) for hospital effluent, 259 and 573 μg L(-1) for WWTP influent and 19 and 118 μg L(-1) for WWTP effluent; c) the variable contribution of hospital effluents to the PPCP loads into the WWTP influents (contribution ranging between 1% (WS-2) and 59% (WS-3); d) the PPCP load reduction after treatment for all WS reaching more than 95% for WS using activated sludge processes (WS-2 and WS-4), with inflow above 6500 m(3) d(-1), and having a lower percentage of hospital effluent in the WWTP influent; e) the relevance of four therapeutical categories for the PPCP load in WWTP effluents (analgesics, antidiabetics, antiepileptics and psychoanaleptics); and f) the risk quotients calculated using screening-level Predicted Non Effect Concentration indicate that WWTP effluents contain 33 PPCPs with potential medium to high ecological risk. To our knowledge no other monitoring investigation published in the scientific literature uses direct-injection methods to cover as many PPCPs and therapeutical categories in different types of WS.

摘要

美国环保署的两个地区实验室开发了直接进样 LC/MS/MS 方法,用于测量水中的药品和个人护理产品 (PPCPs)。这两个实验室联合起来,准备分析属于 20 多种治疗类别的 185 种 PPCPs(其中 74 种重叠),检测限达到 ppt 级。与纽约州萨福克县合作,实验室对属于 4 个供水系统 (WS) 的 72 个样本进行了 PPCP 分析。这些样本是在 WS 的不同阶段采集的(医院废水、WWTP 进水/出水),以评估医院排放物中 PPCP 的相关性、对 WWTP 性能的影响以及在处理过程中未去除的分析物带来的潜在生态风险。主要发现包括:a) 对于大多数重叠 PPCPs,两个实验室之间的准确度可以接受,对于较高浓度的 PPCPs ,一致性更好;b) 在所研究的所有 WS 中都测量到了 PPCPs,医院废水的总 PPCP 浓度范围为 324 至 965μg/L,WWTP 进水的浓度范围为 259 至 573μg/L,而 WWTP 出水的浓度范围为 19 至 118μg/L;c) 医院废水对 WWTP 进水 PPCP 负荷的可变贡献(贡献范围为 1%(WS-2)至 59%(WS-3);d) 所有 WS 的处理后 PPCP 负荷减少了 95%以上,对于采用活性污泥工艺的 WS(WS-2 和 WS-4),进水流量超过 6500m3/d,且 WWTP 进水中医院废水的比例较低;e) 四个治疗类别对 WWTP 出水中 PPCP 负荷的相关性(镇痛药、抗糖尿病药、抗癫痫药和精神兴奋药);f) 使用筛选水平预测无效应浓度计算的风险商数表明,WWTP 出水中含有 33 种具有中等至高生态风险的 PPCP。据我们所知,在科学文献中,没有其他监测调查使用直接进样方法来涵盖不同类型 WS 中的如此多的 PPCPs 和治疗类别。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验